Nuevolution A/S (Copenhagen, Denmark) is a drug discovery company dedicated to revolutionize fragment- and high throughput-based lead discovery.
The company’s drug discovery platform, Chemetics™, excels at being more cost-efficient, faster and better than conventional methods in identifying drug leads to virtually any therapeutic target.
Nuevolution is successfully exploiting its platform technology both through internal programs, fully partner-funded programs and through collaborative projects.
Nuevoloution was acquired by Amgen in 2019
For more information, please contact:
Phone: +45 4081 4889